CSPC Pharmaceutical Group Ltd logo

CSPC Pharmaceutical Group Ltd

$ 0.96 0 (0%) 09:40 AM EST
On watch
P/E:
14.13
P/B:
2.83
Market Cap:
$ 11.86B
Enterprise V:
$ 10.07B
Volume:
100.00
Avg Vol (2M):
2.80K
Also Trade In:
Volume:
100.00
Market Cap $:
11.86B
PE Ratio:
14.13
Avg Vol (2-Month):
2.80K
Enterprise Value $:
10.07B
PB Ratio:
2.83
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
CSPC Pharmaceutical Group, or CSPC, is one of the largest drug manufacturers in China. The company has a diversified portfolio of generic drugs, bulk drugs, and drugs with improved formulations. Its R&D pipeline is focused on cardio-cerebrovascular diseases, digestion and metabolic diseases, oncology, neurology, and anti-infectives.

Financials (Next Earnings Date:2023-03-22 Est.)

CHJTF's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:CHJTF

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 4,536.57
EPS (TTM) ($) 0.07
Beta -0.26
Volatility % 38.62
14-Day RSI 22.3
14-Day ATR ($) 0.004153
20-Day SMA ($) 0.99418
12-1 Month Momentum % -18.03
52-Week Range ($) 0.92 - 1.29
Shares Outstanding (Mil) 11,933.22

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

CSPC Pharmaceutical Group Ltd Filings

Document Form Filing Date
No Filing Data

CSPC Pharmaceutical Group Ltd Analysis

Share your research

Headlines

See More
No news.